FLEN HEALTH IRE LIMITED

Founded in 2000, FLEN HEALTH IRE LIMITED is a specialist biotechnology company that creates innovative wound‑ and skin‑healing solutions for healthcare professionals and patients across the globe. Drawing on more than two decades of research, the firm combines cutting‑edge science with a patient‑centred ethos to preserve the healthy tissue in a wound while eliminating the factors that impede recovery, thereby providing an optimal environment for rapid, painless healing.

The product portfolio includes Flaminal® for acute and chronic wounds, Flamigel® for superficial injuries such as grazes, first‑degree burns and sunburns, Flamigel® RT for skin care during radiotherapy, Extracalm® to soothe acute and chronic itch, and Flamirins® for effective wound cleaning. These solutions address a wide range of conditions—from radiotherapy‑induced skin damage and pressure or leg ulcers to infected wounds and irritating skin reactions. With a European network that now spans the United Kingdom, Belgium, the Netherlands, Luxembourg, Italy, Germany and Ireland, FLEN HEALTH serves clinicians and patients who seek safe, easy‑to‑use products that help them “live the life they love.”